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Abstract
Background: Two main genes encoding the catalytic subunits Cα and Cβ of cyclic AMP
dependent protein kinase (PKA) have been identified in all vertebrates examined. The murine,
bovine and human Cβ genes encode several splice variants, including the splice variant Cβ2. In
mouse Cβ2 has a relative molecular mass of 38 kDa and is only expressed in the brain. In human
and bovine Cβ2 has a relative molecular mass of 47 kDa and is mainly expressed in lymphoid
tissues.
Results: We identified a novel 47 kDa splice variant encoded by the mouse Cβ gene that is highly
expressed in lymphoid cells. Cloning, expression, and production of a sequence-specific antiserum
and characterization of PKA catalytic subunit activities demonstrated the 47 kDa protein to be a
catalytically active murine homologue of human and bovine Cβ2. Based on the present results and
the existence of a human brain-specifically expressed Cβ splice variant designated Cβ4 that is
identical to the former mouse Cβ2 splice variant, the mouse splice variant has now been renamed
mouse Cβ4.
Conclusion: Murine lymphoid tissues express a protein that is a homologue of human and bovine
Cβ2. The murine Cβ gene encodes the splice variants Cβ1, Cβ2, Cβ3 and Cβ4, as is the case with
the human Cβ gene.
Background
Cyclic AMP dependent protein kinase (PKA) is a holoen-
zyme that consists of a regulatory (R) subunit dimer and
two catalytic (C) subunits [1]. The enzyme is activated
when two cAMP molecules bind each R subunit, causing
a conformational change that releases the C subunits [2].
Different isoforms of both R and C subunits exist. Four
separate R subunit genes designated RIα, RIβ, RIIα and
RIIβ have been identified and characterized in all primates
investigated [3,4]. In most species investigated three genes
encoding the C isoforms have been identified and desig-
nated Cα, Cβ and PrKX. PrKX is an X chromosome
encoded protein kinase [5] that has, despite low homol-
ogy to Cα and Cβ, been identified as a PKA C subunit with
the ability to release the R subunit in a cAMP-dependent
fashion [1]. A murine homologue of PrKX termed PKARE
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intron-less gene transcribing the mRNA for Cγ has been
identified. Cγ represents a testis-specific retroposon [7]. In
the mouse a C subunit pseudogene has been identified
and designated Cx [8].
Several splice variants of Cα and Cβ, arising from alterna-
tive splicing of the first exon in the Cα and Cβ genes, are
responsible for further diversity. The Cα gene encodes two
splice variants (Cα1 and Cαs/Cα2) in mouse [9], human
[10] and sheep [11]). In human 10 different splice vari-
ants encoded by the Cβ gene have been identified and
called Cβ1, Cβ2, Cβ3, Cβ4, Cβ4ab, Cβ4abc, Cβ3ab,
Cβ3abc, Cβ3b and Cβ4b [12]. In the mouse and bovine
three and two Cβ splice variants have been identified,
respectively. In bovine they are designated Cβ1 and Cβ2
[13,14] and in mouse they are designated Cβ1, Cβ2 and
Cβ3 [15,16]. Cα1 and Cβ1 are ubiquitously expressed,
while the other splice variants show a more tissue
restricted expression pattern. CαS/Cα2 is solely expressed
in sperm cells [10,11]. Whereas expression of the human
Cβ2 splice variant is enriched in lymphoid tissues [17,18],
it shows a more widespread pattern of expression in the
bovine [14] and is restricted to the brain in mice [16]. The
majority of the other Cβ splice variants identified, which
include human and murine Cβ3 and human Cβ4 as well
as the human Cβ3 and Cβ4 abc variants, are only detected
in nerve cells and the brain [12,16,17].
A number of reports have demonstrated that both the Cα1
and Cβ1 isoforms have a relative molecular mass of
approximately 40 kDa when analysed by SDS-PAGE [15].
In contrast, human and bovine Cβ2 have a relative molec-
ular mass of 47 kDa [14,18] whereas in the mouse it is 38
kDa [16]. Both human and murine Cβ3 are 38 kDa, as is
also the case with human Cβ4 [12,16,17]. For the human
Cβ3 and Cβ4 abc variants, the relative molecular masses
have not been determined.
We investigated the expression of C subunits in various
murine tissues and identified two immunoreactive pro-
teins of approximately 40 and 47 kDa. Whereas the 40
kDa band was ubiquitously expressed, the 47 kDa band
was restricted to lymphoid tissues such as thymus, spleen
and lymph node. Based on this we examined the activity,
level and apparent molecular sizes of Cβ splice variants in
immune cells. Using spleen cells from wild type and mice
mutant for the Cβ gene we demonstrated that the 40 kDa
band was Cβ1 whereas the 47 kDa protein was the murine
homologue of human and bovine Cβ2. The novel murine
Cβ2 was shown to be an active protein kinase that was
immunodetected by an antiserum made against the
human Cβ2 specific sequence. Based on this, together
with sequence homology searches and sequence compar-
isons, we conclude that the previously reported murine
Cβ2 is a homologue of human Cβ4. Thus, the murine Cβ
gene encodes the splice variants Cβ1, Cβ2, Cβ3 and Cβ4,
as is the case with the human Cβ gene.
Results
Murine spleen cells express Cα1, Cβ1 and a novel 47 kDa 
Cβ splice variant enriched in lymphoid tissues
When lysates made from various murine tissues were sep-
arated by SDS-PAGE and immunostained with a commer-
cially available pan C antibody (Figure 1A), a 40 kDa
band was detected in all tissues. In addition to this ubiq-
uitously expressed band a weaker band of 47 kDa was
detected, that seemed to be restricted to lymphoid tissues,
as it could only be detected in lymph nodes, spleen and
thymus. No expression was detected in brain, heart, lung,
liver, kidney and skeletal muscle.
To investigate identity of these C immunoreactive bands,
spleen cell lysates from wild type (WT) mice and mice that
were heterozygous (+/-) or homozygous (-/-) for a null
mutation in the Cβ gene [19] and a human T cell lysate
were immunoblotted with the pan C antibody (Figure
1B). In the human T cell lysate two immunoreactive
bands of 40 and 47 kDa were identified. These protein
bands have previously been shown to be Cα1 (40 kDa)
and Cβ2 (47 kDa) [18]. The 47 kDa immunoreactive pro-
tein band was detected in the spleen cell lysate from WT
and Cβ+/- mice, but was absent in the Cβ-/- lysate, imply-
ing that it represents a Cβ splice variant. Furthermore, in
the Cβ-/- lysate, the 40 kDa protein band appeared weaker
in intensity. This was confirmed by densitometric scan-
ning of the 40 kDa bands in Figure 1B (results not shown)
which revealed a 40 % reduction in intensity of the 40
kDa band in the Cβ-/- lysate. Together this implies that
Cβ1 (40 kDa) may be expressed in mouse spleen cells.
Spleen cell lysates from WT and Cβ mutant mice were also
tested for PKA-specific phosphotransferase activity by
incorporation of 32P from [γ-32P]-ATP into the PKA-spe-
cific substrate Kemptide (Figure 1C). Phosphotransferase
activity was also measured in the presence of PKI to dem-
onstrate that kinase activity was PKA-specific (black bars,
cAMP/PKI). PKA-specific activity was reduced by 35 and
66 % in Cβ+/- and Cβ-/- mice, respectively, compared to
WT (Cβ+/+) mice. This indicates that Cβ contributes sig-
nificantly to PKA activity in mouse spleen cells.
To further investigate the identity of the 40 and 47 kDa
protein bands, we analysed C subunit expression and PKA
kinase activity in mice lacking the Cβ1 splice variant
(Cβ1-/-) [20]. Figure 1D demonstrates that the 47 kDa C
subunit immunoreactive band is present in cell lysates
from both WT and Cβ1-/- mice. It should however be
noted that the 40 kDa protein band was clearly weaker in
intensity in lysate from Cβ1-/- mice. Densitometric scan-Page 2 of 10
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C subunit identity and PKA specific kinase activity in murine spleen cellsFig re 1
C subunit identity and PKA specific kinase activity in murine spleen cells. (A) SDS-PAGE (12.5 % gels) and anti-C 
immunoblotting of lysates (90 μg/lane) from lymph nodes, spleen, thymus, brain, heart, lung, liver, kidney and skeletal muscle 
from a WT mice. Arrows indicate molecular mass standards (left) and C subunit identities (right). (B) SDS-PAGE (12.5 % gels) 
and anti-C immunoblotting of cell lysates (60 μg/lane) from human T cells and from wild type (Cβ+/+), Cβ heterozygote (Cβ+/
-) and Cβ knockout (Cβ-/-) mice. Arrows indicate molecular mass standards (left) and C subunit identities (right). (C) PKA-
specific phosphotransferase activity in spleen lysates (1 μg/ml) isolated from wild type (Cβ+/+), Cβ heterozygote (Cβ+/-) and 
Cβ knockout (Cβ-/-) mice. Activity was measured in the absence (empty bars, basal) or presence (gray bars, cAMP) of 5μM 
cAMP or both cAMP and PKI (black bars, cAMP/PKI). Activities in the extracts from the mutant mice are given relative to the 
activity in the lysates from wild type cell lysate, which are set to 100 %. Bars represent mean activities of three experiments ± 
standard deviation. Percentage reductions in activities were calculated after subtraction of non specific kinase activity (black 
bars) and are indicated with an arrow. (D) SDS-PAGE (12.5 % gels) and anti-C immunoblotting of spleen lysates (60 μg/lane) 
from wild type (Cβ1+/+) and Cβ1 knockout (Cβ1-/-) mice. Arrows indicate molecular mass standards (left) and C subunit 
identities (right). (E) PKA-specific phosphotransferase activity in spleen lysates (1 μg/ml) from wild type (Cβ1+/+) and Cβ1 
knockout (Cβ1-/-) mice were measured and presented as described in C. Bars represent mean activities of three experiments 
± standard deviation.
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tude (approximately 30 %, results not shown) as that
monitored in the Cβ-/- mice. Together with the fact that
we also measured a 27 % reduction in PKA kinase activity
in the Cβ1-/- mice lysates (Figure 1E) this demonstrated
that Cβ1 is expressed in mouse spleen cells. Finally, the
fact that reduction in PKA kinase activity in the Cβ-/- was
approximately twice as much at that observed in the Cβ1-
/- (66 % as opposed to 27 %) strongly implies that the
lymphoid tissue specific 47 kDa protein is a Cβ splice var-
iant and that it contributes significantly to PKA kinase
activity in mouse spleen cells.
Cloning and expression of a novel catalytically active 
murine Cβ splice variant homologous to human Cβ2
Our observations that murine spleen cells express a 47
kDa anti-C immunoreactive protein that is absent in the
Cβ-/- animals, and co-migrates with human Cβ2, suggest
that the mouse expresses a Cβ2 subunit homologous to
the human Cβ2 subunit. In order to investigate this, we
initially performed a homology search in the National
Center for Biotechnology Information (NCBI) BLAST
(tblastn) search tool using the human Cβ2 specific pep-
tide sequence. We identified a region with high sequence
similarity to the human exon 1–2 sequence in the pub-
lished mouse genome [21]. This sequence was located in
the mouse Cβ gene upstream of exon 2 (Figure 2A). Based
on this information and the fact that all C subunits iden-
tified so far only differ in the domain encoded by alterna-
tive use of exon 1, we postulated a hypothetical cDNA
sequence using this mouse exon 1–2 sequence and the
known murine Cβ cDNA sequence [15] (Figure 2A, bot-
tom). To confirm mRNA expression of this sequence, oli-
gonucleotide primers corresponding to the 5'-
untranslated and 3'-untranslated regions of the cDNA
were synthesised and used for reverse transcriptase PCR of
total RNA from mouse thymus since Cβ2 expression has
earlier been reported to be enriched in human thymus
[17]. PCR products were subcloned into pCR-Blunt-II-
TOPO vector. Nucleotide sequencing (Medigenomix, Ger-
many) and amino acid sequence deduction (Figure 2B),
followed by comparison of the unique N-terminal end
[17,22] with corresponding sequences in human, bovine,
mouse and zebra fish (Figure 2C), confirmed the novel
sequence as the murine Cβ2 homologue.
It has previously been demonstrated that a cDNA encod-
ing the bovine Cβ2 was not active when transfected into
CHO cells [22]. To determine if the mouse Cβ2 cDNA
encodes an active protein kinase, the cDNA was amplified
by PCR and subcloned into pcDNA-DEST40 (Gateway
Technology System, Invitrogen). To optimize for efficient
protein expression, a Kozak sequence was introduced in
the 5'-end. Moreover, two different 3'-ends were made,
one including and one excluding a stop codon to facilitate
native and tagged expression, respectively (Figure 3A).
The new plasmid was designated pcDNA-DEST40mCβ2
and transfected into HEK 293T cells. As a positive control
pEF-DEST51Cα1, which expresses human Cα1 (hCα1),
was used. Mock transfected cells served as a negative con-
trol. Twenty-four hours after transfection cells were lysed
and subjected to immunoblotting using a pan C antibody.
This revealed expression of an immunoreactive protein of
47 kDa in cells transfected with mCβ2, and a 40 kDa pro-
tein in cells transfected with hCα1. A weak 40 kDa band
could also be seen in mCβ2 and mock transfected cell
lysates (Figure 3B), representing endogenous Cα1. In
order to test for enzyme activity of the expressed Cβ2, the
same cell lysates were analysed for PKA-specific phospho-
transferase activity against Kemptide. This demonstrated a
more than 10-fold increased enzyme activity in the cells
transfected with mCβ2 and hCα1 compared to the mock-
transfected cells (Figure 3C). The PKA specific inhibitor
PKI abolished this activity, implying that the activity
observed is PKA-specific and that mouse Cβ2 is an active
PKA enzyme. It should be noted that the C-terminally
tagged Cβ2 was kinase inactive and was not used for fur-
ther experiments (results not shown).
In order to further demonstrate that the cloned sequence
expressed a murine Cβ2 (mCβ2) specific sequence, we
developed an antiserum by immunizing two rabbits with
two mCβ2 specific peptides (Figure 3D). Immunoreactiv-
ity of the resulting antiserum (Anti-mCβ2) was tested by
immunoblotting using lysates from HEK 293T cells trans-
fected with either mCβ2 or human Cα1 (hCα1) (Figure
3E). This revealed that the size of the protein recognized
by the anti-mCβ2 serum was determined to be 47 kDa by
comparison with an identical blot probed with the pan C
antibody. It should be noted that the anti-mCβ2 serum
did not appear to cross-react with expressed hCα1.
Discussion
The present report demonstrates a lymphoid tissue spe-
cific 47 kDa Cβ subunit which together with Cβ1 (40
kDa) is responsible for 66 % of PKA specific enzyme activ-
ity in spleen cells. The 47 kDa Cβ subunit was cloned and
shown to be an active murine PKA Cβ splice variant. Based
on a sequence homology search, and production of a spe-
cific antiserum, we conclude that the 47 kDa protein is the
murine homologue of human and bovine Cβ2. Further-
more, sequence comparison also led us to conclude that
the previously published murine Cβ2 is the murine
homologue of human Cβ4. Taken together with previous
reports our results demonstrate that the murine Cβ gene
encodes Cβ1, Cβ2, Cβ3 and Cβ4.
Expression of Cβ1 in murine spleen was indirectly dem-
onstrated by reduced immunoreactivity of the 40 kDa
band and a 27 % reduction in PKA-specific kinase activityPage 4 of 10
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Identification of a novel mouse cDNA sequence encoding a Cβ splice variant homologous to human Cβ2Figure 2
Identification of a novel mouse cDNA sequence encoding a Cβ splice variant homologous to human Cβ2. (A) 
Schematic representation of the human (upper) and murine (lower) Cβ gene. The intron sizes between exons (vertical lines) 
are indicated by horizontal arrows. A region of high similarity (identified by BLAST (tblastn) homology search in the published 
mouse genome) to human exon 1–2 is indicated between the genes (bent/vertical lines). A hypothetical cDNA sequence is indi-
cated, with an 1197 base pair open reading frame (ORF 1197 bp), and a start (ATG) and stop (TAG) translation codon for 
murine Cβ2 is given, based on the identified sequence and the known mouse Cβ cDNA sequence (bottom). (B) Deduced 
amino acid sequence of mouse Cβ2 shown in one letter code. The Cβ2 splice variant specific sequence of 62 amino acids is 
underscored. (C) Cβ2 specific sequences from human, bovine, mouse and zebrafish were aligned and amino acid sequences 
conserved between species were boxed. Compared to the level of conservation in the catalytic core of C subunits, the Cβ2 
specific sequence shows a lesser degree of conservation.
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Murine Cβ2 cDNA encodes an active protein kinase of 47 kDa recognized by a Cβ2-specific antiserumFigur  3
Murine Cβ2 cDNA encodes an active protein kinase of 47 kDa recognized by a Cβ2-specific antiserum. (A) 
Primers used to amplify mouse Cβ2 cDNA for insertion into pENTR/D-TOPO (Gateway system, Invitrogen). The upper 5'-
end primer (upper sequence left) was designed to produce an insert with a Kozak sequence associated with the start codon 
(ATG). Two different 3'-end primers (lower right two sequences) were designed in order to include or exclude the stop 
codon (TAG). In the absence of the stop codon, the mouse Cβ2 would be expressed with a C-terminal tag, which is contained 
in the vector (Gateway, Invitrogen). Mouse Cβ2 cDNA was PCR amplified and subcloned into the pcDNA-DEST40 expression 
vector to yield pcDNA-DEST40 mCβ2. (B) HEK 293T cells (3.5 × 105 cells/ml) were transfected with 2μg DNA/ml of pcDNA-
DEST40mCβ2 (mCβ2), mock-transfected (mock), or transfected with pEF-DEST51hCα1 (hCα1) for 24 h. Cells were lysed 
and analysed by SDS-PAGE and anti-pan C immunoblotting. Note that mCβ2, but not mock or hCα1 transfected cell extracts, 
contained an anti-C immunoreactive protein of 47 kDa. All lanes revealed a 40 kDa protein band which was most intense in 
cells transfected with pEF-DEST51hCα1 . (C) The same lysates were analysed for PKA-specific kinase activity in the absence 
(empty bars, basal) or presence (gray bars, cAMP) of 5μM cAMP, or both cAMP and PKI (black bars, cAMP/PKI). Activities 
were calculated relative to the activity of the mock-transfected lysate, which was set to 100 %. Bars represent mean activities 
of three experiments ± standard deviation. (D) The sequence of the two mCβ2 specific peptides (boxed) used to immunize 
rabbits to make mCβ2 specific antiserum. (E) Two rabbits were co-immunized with the two peptides and the resulting 
immune sera tested for immunoreactivity and specificity using cell extracts of HEK 293T cell transfected with mCβ2 (pcDNA-
DEST40mCβ2) or hCα1 (pEF-DEST51hCα1). Left panel: The mCβ2 serum recognized a 47 kDa immunoreactive protein in 
mCβ2 but not in hCα1 transfected cell lysates. No cross-reactivity to human Cα1 could be observed. Right panel: Immunob-
lotting of the same lysates with a pan anti-C antibody revealed a 47 and a 40 kDa immunoreactive protein in the two extracts 
respectively, confirming expression of transfected constructs.
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BMC Biochemistry 2006, 7:20 http://www.biomedcentral.com/1471-2091/7/20in the Cβ1-/- mouse. Cβ1 expression in murine lym-
phocytes is in conflict with our previous observations in
human T lymphocytes [18], which apparently do not
express this splice variant. If this is also the case for murine
T cells, it implies that other cell types may account for the
presence of Cβ1 in our cell extracts, since spleen cells are
a mixture of various immune cells, including B and T cells
as well as macrophages and monocytes.
Our results demonstrate the existence of a sequence in the
murine genome homologous to the human and bovine
Cβ2-specific sequence. In addition, we observed a 47 kDa
anti-C immunoreactive protein that was absent in Cβ-/-
but not in Cβ1-/- mice. Because the cloned and expressed
Cβ variant was 47 kDa as demonstrated by immunoreac-
tivity to a pan C antibody and a serum made against the
N-terminus of the novel protein, and because the only
known 47 kDa PKA C subunit is the human and bovine
Cβ2 [17,22], we conclude that the novel C subunit is the
murine Cβ2 homologue. The existence of the 47 kDa Cβ2
homologue is in conflict with our previous report, which
showed the presence of Cβ2 in several mammalian spe-
cies, including monkey, dog, man and bovine, but failed
to demonstrate the splice variant in rodents [17]. This was
concluded based on a Zoo-blot (Southern blot with
genomic DNA from various species) analysis using a
probe spanning the human Cβ2-specific sequence. Failure
to identify a murine Cβ2 may have been due to low
homology between Cβ2 of various species, which we also
discovered in our data-base searches comparing the Cβ2
specific sequence of human, bovine, mouse and zebra fish
(Figure 2C). Interestingly, the Cβ2 specific sequence was
fairly well conserved even in the fish genome, indicating
the presence of Cβ2 in all vertebrates. A lower of degree of
conservation is a feature generally associated with
sequences not directly involved in catalysis, which again
may suggest a more structural role for the N-terminal part
of the protein.
Expression of Cβ2 protein seemed to be mostly restricted
to lymphoid tissues, as the 47 kDa band was present in
lymph nodes, spleen and thymus, but not detectable in
brain, heart, lung, liver, kidney and skeletal muscle. In an
earlier report Cβ2 mRNA was detected in bovine brain,
heart, skeletal muscle, spleen and liver [14]. Moreover, in
human Cβ2 has been detected by Northern blotting in
human kidney in addition to the same immune tissues as
demonstrated for mouse [17]. The fact that we were una-
ble to detect Cβ2 protein in all tissues described in bovine
and in kidney of human may imply that the protein is not
present in these tissues or that the level of expression is
below the level of detection for the antibodies used here.
Using peptides corresponding to the Cβ2 specific
sequence, we made a polyclonal antibody. This antiserum
was shown to be Cβ2 specific in immunoblot assays.
Guthrie et al. [16] identified three Cβ splice variants in
mouse, with Cβ2 expressed exclusively in the brain,
encoding an additional 2 amino acids at the N-terminus
by alternative use of exons. It is therefore smaller than
human and bovine Cβ2 and is not expressed in the same
tissues. In fact, the previously described mouse Cβ2 is
identical to the human splice variant designated Cβ4,
which is expressed in the brain [17]. Based on this evi-
dence, the previously described murine Cβ2 has now been
renamed murine Cβ4. Moreover, based on this and previ-
ous reports, we conclude that all mammals contain the
isoforms Cβ1, Cβ2, Cβ3 and Cβ4. These facts call for a
revision of the present Cβ splice variant nomenclature as
given in Table 1.
Conclusion
We conclude that the murine homologue of human and
bovine Cβ2 is expressed in lymphoid cells. The previously
published murine Cβ2 [16] is the murine homologue of
human Cβ4 [17]. Taken together with previous reports we
conclude that the murine Cβ gene encodes Cβ1, Cβ2, Cβ3
and Cβ4.
Methods
Mice
Cβ-/- mice on a mixed C57BL/6:129SV/J background [19]
were obtained from Professor G. Stanley McKnight
(Department of Pharmacology, University of Washington
School of Medicine, Seattle, 98195, USA). All use of ani-
mals has been approved and registered by the Norwegian
Animal Research Authority. Animals were housed in a
temperature controlled (22°C) facility with a strict 12
hour light/dark cycle, and allowed the RM1 diet (Special
Table 1: Nomenclature and relative sizes of human, bovine and murine Cβ splice variants
Human Cβ1 Cβ2 Cβ3** Cβ4** [23, 17]
Bovine Cβ1 Cβ2 [13, 14]
Murine (old)* Cβ1 Cβ3 Cβ2 [15, 16]
Murine (new)* Cβ1 Cβ2 Cβ3 Cβ4
Size (kDa) 40 47 38 38
*The old and new murine nomenclature has been indicated.
**The abc variants of Cβ3 and Cβ4 (Cβ4ab and Cβ 4abc [17] and Cβ3ab, Cβ3abc, Cβ3b and Cβ4b [12]) have not been included in the table.Page 7 of 10
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before euthanasia. Heterozygote animals were crossed
and offspring genotyped by PCR. The KO allele was
detected using a forward primer 5'-ccgcttgggtggagaggctat-
3' that hybridizes inside the neomycin cassette that
replaced exon 2 by homologous recombination when the
KO gene was generated, and a reverse primer 5'-gccctcctt-
gccgcct-3' that hybridizes downstream of exon 2, giving a
~1.4 kb product. The WT allele was detected using a for-
ward primer 5'-cggtgctggcaacagaaggtg-3' that hybridizes
upstream of exon 2 and a reverse primer 5'-gaagggaacg-
gaggcgagtga-3' that hybridizes inside exon 2, giving a ~1.2
kb product.
Preparation of primary human and mouse lymphocytes
Human T cells were purified from buffy coates of healthy
blood donors (Ullevaal University Hospital Blood Centre,
Oslo, Norway). Written approval was obtained from all
donors. First, mononuclear cells were isolated using den-
sity gradient centrifugation (Lymphoprep; Nycomed,
Oslo, Norway) as described elsewhere [24]. The cells were
then enriched for T cells by negative selection using anti-
CD14 and anti-CD19 coated magnetic beads (Dynal,
Oslo, Norway).
Spleens were dissected from CO2-euthanized mice. Single
cell suspensions in PBS (Phosphate buffered saline, pH
7.4) were obtained by squeezing tissue through a mesh
cup (Sigma), and erythrocytes were removed by lysing in
hypotonic buffer (17 mM Tris, 140 mM NH4Cl, pH 7.2).
Homogenization and preparation of protein lysates
Cells were washed in PBS and lysed by sonication on ice
in a sucrose-containing lysis buffer (5 mM KH2PO4, 5 mM
K2HPO4, 250 mM sucrose, 1 mM EDTA, 0.5 % Triton X-
100) with 1 mM DTT, 1 mM PMSF and a protease inhibi-
tor cocktail (Sigma). Tissue samples were homogenised
on ice in the same buffer using Ultra thurrax (3 × 15 sec-
onds, full speed). Lysates were cleared by centrifugation at
15,000 × g for 15 minutes at 4°C. Protein concentration
was determined by the Bradford method (Bio-Rad Labo-
ratories).
Kinase assay
PKA-specific kinase activity was determined as described
previously [25,26]. Briefly, 10 μl lysate (1μg/ml) was
added to a 40 μl reaction mix to make a final concentra-
tion of 30 μM Kemptide, 200 μM of ATP containing 2 μCi/
mmol [γ-32P]ATP (Amersham Biosciences), 10 mM
MgAc2, 20 mM Tris (pH 7.4) in the presence or absence of
5μM cAMP and 30 μM PKI. After incubation for 9 minutes
at 30°C, 25 μl of the reaction was spotted onto phos-
phocellulose paper (P81 Whatman), which was washed
four times in 75 mM phosphoric acid and finally in 95%
ethanol. Filters were air-dried, immersed in Opti-Fluor
(Packard Biosciences) and counted in a liquid scintilla-
tion counter.
SDS-PAGE and immunoblotting
Lysates were separated by SDS-PAGE in 12.5 % gels (Cri-
terion Precast Gels, BioRad) and transferred to PVDF
membranes by electroblotting. Membranes were blocked
in 5% skimmed milk powder in TBST (Tris-buffered saline
containing 0.1 % Tween-20) for 1 h at room temperature,
and incubated overnight at 4°C with primary antibodies
(pan C antibody (Anti-C, BD Transduction Laboratories)
or mCβ2 antiserum (Anti-mCβ2, Sigma)) diluted in TBST.
Membranes were washed for 1 h in TBST and further incu-
bated with horseradish peroxidase-conjugated secondary
antibodies (MP Biomedicals). Membranes were washed
and finally developed using SuperSignal® West Pico
Chemiluminescent (Pierce).
Cloning of mCβ2
A homology search in the murine genome was performed
in the National Center for Biotechnology Information
(NCBI) BLAST (tblastn) search tool using the human Cβ2
specific peptide sequence. A region similar to the human
exon 1–2 sequence was identified and a sequence in the
mouse genome was postulated as mouse exon 1–2. Based
on this a hypothetical murine Cβ2 cDNA was deduced
which contained this sequence and the rest of the known
murine Cβ cDNA sequence thatspans the sequence
encoded by exon 2 through exon 10. To verify the exist-
ence of murine Cβ2 mRNA, total RNA was isolated from
a mouse thymus using the RNeasy Mini Kit (Qiagen) and
total cDNA was synthesized using the Promega Reverse
Transcription System (Promega). Potential full-length
mCβ2 cDNAs were amplified with PCR (Pfu Ultra ampli-
fication system, Stratagene) using several different oligo-
nucleotide primers corresponding to the 5'-untranslated
and 3'-untranslated regions of the predicted cDNA. Three
different forward primers (F1: 5'-gctcttagcgtcttggtagg-3',
F2: 5'-aaacacttgcagttacttta-3' and F3: 5'-ttctgaaaacactt-
gcagtt-3') and three different reverse primers (R1: 5'-
cccacagaggtcggt-3', R2: 5'-gacctcacgcagttg-3' and R3: 5'-
acactgatgacgcagga-3') were combined into nine different
primer sets (set 1: F1+R1, set 2: F1+R2, set 3: F1+R3, set 4:
F2+R1, set 5: F2+R2, set 6: F2+R3, set 7: F3+R1, set 8:
F3+R2 and set 9: F3+R3). Of the primer sets (Sets 1, 3, 4,
6, 7 and 9) that resulted in amplification of a single DNA
band of the right size (based on the theoretical lengths of
the various PCR products-between 1300 and 2000 bp),
Set 1 and 3 were used to amplify mCβ2 cDNA in two par-
allel PCR reactions. The PCR products were subcloned
into the pCR-Blunt-II-TOPO vector (Invitrogen) and
sequenced by Medigenomix (Martinsried, Germany).Page 8 of 10
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For eukaryotic expression of mCβ2, the mCβ2 cDNA was
cloned into the mammalian expression vector pcDNA-
DEST40 (Gateway Technology System, Invitrogen), dur-
ing which primers were made to introduce a Kozak
sequence at the '5-end. In addition, two '3-end primers
were used to introduce or exclude a stop codon in order to
express mCβ2 with or without an N-terminal tag encoded
by the expression vector itself (Invitrogen). For primer
sequences, see figure 3A. PCR products were subcloned
into pENTR/D-TOPO vector and transformed into bacte-
ria. A positive clone was purified by mini-preparation
(Jetquick Plasmid Spin Kits, Genomed), digested by
restriction enzymes and sequenced. Using the LR-clonase
recombination reaction, the insert of the pENTR/D-TOPO
vector was recombined into the pcDNA-DEST40 expres-
sion vector and transformed into bacteria. Positive clones
were selected and purified by mini-preparation (Jetquick
Plasmid Spin Kits, Genomed), restriction enzyme
digested and sequenced. The new plasmid was designated
pcDNA-DEST40mCβ2.
Transfection
HEK 293T cells were grown in RPMI-1640 medium sup-
plemented with 5 % fetal calf serum. Semi-confluent cells
(3.5 × 105 cells/ml) were transfected with human Cα1
(pcDNA-DEST40hCα1 [18]) or murine Cβ2 (pcDNA-
DEST40mCβ2) at a concentration of 2 μg DNA/ml using
LipofectAMINE2000 (Invitrogen) as described by the
manufacturer. Cells were then incubated for 24 hours
before use in experiments.
Production of mCβ2 antiserum
Antisera production, including peptide synthesis, KLH-
conjugation and immunization of rabbits was performed
by Sigma-Genosys, UK. Rabbits were co-immunized with
two peptides with sequences from the Cβ2 specific N ter-
minal end of murine Cβ2, SRLFHRHSRGTAQE and
RAALEDDGLRASEH (see figure 3D). Both peptides con-
tained an additional Cys residue at the C-terminus for
thiol-coupling to KLH (keyhole limpet hemocyanin). The
conjugate was dissolved in PBS and injected with Freund's
adjuvant. For the initial injection, 200 μg of conjugate was
injected with Complete Freund's Adjuvant, and for subse-
quent injections 100 μg of conjugate with Incomplete Fre-
und's Adjuvant was injected. Immunizations were given
subcutaneously at a single site every two weeks for a total
of 6 times. Blood samples were collected 4 times during
this period.
Abbreviations
WT, +/+, wild type; +/-, heterozygote; KO, -/-, knockout;
PKA, cyclic AMP-dependent protein kinase, protein kinase
A
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